Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2021

01-06-2021 | Gliclazide | Research article

Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients

Authors: Elaheh Foroumandi, Sorayya Kheirouri, Rahmat Nosrati, Ramin Ghodsi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Login to get access

Abstract

Background and objective

Increased serum levels of advanced glycation end products (AGEs), caspase-3 (Cas-3) and matrix metalloproteinase-9 (MMP-9) have been reported in diabetic patients. This study aimed to evaluate association of anthropometric, dietary, and therapeutic factors with serum levels of methylglyoxal (MGO), carboxymethyl lysine (CML), pentosidine (Pen), Cas-3, and MMP-9 in diabetic patients.

Methods

The current study included 36 diabetic subjects. Dietary intake of the participants was assessed using three-day 24-h recall survey and anthropometric indices were measured. Demographic factors and medication intake of every subject were obtained. Serum levels of CML, MGO, Pen, MMP-9, and Cas-3 were measured using ELISA method.

Results

Gliclazide consumption was positively correlated with MMP-9 and Cas-3, but not AGEs levels. Females had higher MGO level compared with males. Further, CML levels were negatively correlated with BMI and WHR. Dietary protein intake was positively correlated with MMP-9, Cas-3, and MGO levels. As well as dietary energy and fat intake had significant positive relationship with serum Cas-3 concentration.

Conclusion

It is concluded that anthropometric characteristics, dietary intake, and therapeutic medications are possible factors that may determine the circulating levels of AGEs, MMP-9, and Cas-3 in patients with diabetes.
Literature
1.
go back to reference Mukhtar Y, Galalain A, Yunusa U. A modern overvİew on dİabetes mellİtus: a chronic endocrine disorder. European Journal of Biology. 2020;5(2):1–14.CrossRef Mukhtar Y, Galalain A, Yunusa U. A modern overvİew on dİabetes mellİtus: a chronic endocrine disorder. European Journal of Biology. 2020;5(2):1–14.CrossRef
2.
go back to reference Kerner W, Brückel J. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(07):384–6.PubMedCrossRef Kerner W, Brückel J. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(07):384–6.PubMedCrossRef
3.
go back to reference Riddle MC, Herman WH. The cost of diabetes care—an elephant in the room. Diabetes Care. 2018;41(5):929–32.PubMedCrossRef Riddle MC, Herman WH. The cost of diabetes care—an elephant in the room. Diabetes Care. 2018;41(5):929–32.PubMedCrossRef
4.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.PubMedCrossRef Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.PubMedCrossRef
5.
go back to reference Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMedCrossRef Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMedCrossRef
6.
go back to reference Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.PubMedCrossRef Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.PubMedCrossRef
7.
go back to reference Haque N, Salma U, Nurunnabi T, Uddin M, Jahangir M, Islam S, et al. Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pakistan journal of biological sciences: PJBS. 2011;14(1):13–24.PubMedCrossRef Haque N, Salma U, Nurunnabi T, Uddin M, Jahangir M, Islam S, et al. Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pakistan journal of biological sciences: PJBS. 2011;14(1):13–24.PubMedCrossRef
8.
go back to reference Stryker LS. Modifying risk factors: strategies that work diabetes mellitus. J Arthroplasty. 2016;31(8):1625–7.PubMedCrossRef Stryker LS. Modifying risk factors: strategies that work diabetes mellitus. J Arthroplasty. 2016;31(8):1625–7.PubMedCrossRef
9.
go back to reference Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, et al. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health. 2011;11(1):40.PubMedCrossRef Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, et al. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health. 2011;11(1):40.PubMedCrossRef
10.
go back to reference Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, et al. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017;60(9):1601–11.PubMedPubMedCentralCrossRef Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, et al. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017;60(9):1601–11.PubMedPubMedCentralCrossRef
11.
go back to reference Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7(6):452–61.PubMedPubMedCentralCrossRef Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7(6):452–61.PubMedPubMedCentralCrossRef
12.
go back to reference Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt Jr PIH. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochemical Journal. 2016;473(24):4527–50.CrossRef Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt Jr PIH. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochemical Journal. 2016;473(24):4527–50.CrossRef
13.
go back to reference Roberts AC, Porter KE. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res. 2013;10(6):472–82.PubMedCrossRef Roberts AC, Porter KE. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res. 2013;10(6):472–82.PubMedCrossRef
14.
go back to reference Orang Z, Mohsenpour MA, Mozaffari-Khosravi H. Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver: A randomized double-blind clinical trial. Obesity Medicine. 2020;19:100278.CrossRef Orang Z, Mohsenpour MA, Mozaffari-Khosravi H. Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver: A randomized double-blind clinical trial. Obesity Medicine. 2020;19:100278.CrossRef
15.
go back to reference Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, El-Asrar AMA. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012;26(1):56–64.PubMedCrossRef Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, El-Asrar AMA. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012;26(1):56–64.PubMedCrossRef
16.
go back to reference Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. diabetes. 2005;54(6):1615–25. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. diabetes. 2005;54(6):1615–25.
17.
go back to reference Ghodsi R, Kheirouri S. Carnosine and advanced glycation end products: a systematic review. Amino Acids. 2018;50(9):1177–86.PubMedCrossRef Ghodsi R, Kheirouri S. Carnosine and advanced glycation end products: a systematic review. Amino Acids. 2018;50(9):1177–86.PubMedCrossRef
18.
go back to reference Del Turco S, Basta G. An update on advanced glycation endproducts and atherosclerosis. BioFactors. 2012;38(4):266–74.PubMedCrossRef Del Turco S, Basta G. An update on advanced glycation endproducts and atherosclerosis. BioFactors. 2012;38(4):266–74.PubMedCrossRef
19.
go back to reference Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother Res. 2020;34(10):2706–11.PubMedCrossRef Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother Res. 2020;34(10):2706–11.PubMedCrossRef
20.
go back to reference Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci. 2012;317(1–2):1–5.PubMedCrossRef Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci. 2012;317(1–2):1–5.PubMedCrossRef
21.
go back to reference Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, et al. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2009;218(3):360–9.CrossRef Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, et al. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2009;218(3):360–9.CrossRef
22.
go back to reference Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222.PubMedPubMedCentralCrossRef Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222.PubMedPubMedCentralCrossRef
23.
go back to reference Xu J, Chen J, Yu J, Wang HJ, Zhang F, Liu Q, et al. Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy. Cell Physiol Biochem. 2018;48(2):705–17.PubMedCrossRef Xu J, Chen J, Yu J, Wang HJ, Zhang F, Liu Q, et al. Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy. Cell Physiol Biochem. 2018;48(2):705–17.PubMedCrossRef
24.
go back to reference Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol. 2003;75(1):95–108.PubMedCrossRef Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol. 2003;75(1):95–108.PubMedCrossRef
25.
go back to reference Katagiri M, Shoji J, Inada N, Kato S, Kitano S, Uchigata Y. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy. Int Ophthalmol. 2018;38(2):607–15.PubMedCrossRef Katagiri M, Shoji J, Inada N, Kato S, Kitano S, Uchigata Y. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy. Int Ophthalmol. 2018;38(2):607–15.PubMedCrossRef
26.
go back to reference Grünwald B, Vandooren J, Gerg M, Ahomaa K, Hunger A, Berchtold S, et al. Systemic ablation of MMP-9 triggers invasive growth and metastasis of pancreatic cancer via deregulation of IL6 expression in the bone marrow. Mol Cancer Res. 2016;14(11):1147–58.PubMedCrossRef Grünwald B, Vandooren J, Gerg M, Ahomaa K, Hunger A, Berchtold S, et al. Systemic ablation of MMP-9 triggers invasive growth and metastasis of pancreatic cancer via deregulation of IL6 expression in the bone marrow. Mol Cancer Res. 2016;14(11):1147–58.PubMedCrossRef
27.
go back to reference Aung LL, Mouradian MM, Dhib-Jalbut S, Balashov KE. MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. J Neuroimmunol. 2015;278:185–9.PubMedCrossRef Aung LL, Mouradian MM, Dhib-Jalbut S, Balashov KE. MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. J Neuroimmunol. 2015;278:185–9.PubMedCrossRef
28.
go back to reference Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ, et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int. 2011;31(4):543–7.PubMedCrossRef Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ, et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int. 2011;31(4):543–7.PubMedCrossRef
29.
go back to reference Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I. The MMP-9-1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. PLoS ONE. 2014;9(9):e106816.PubMedCrossRef Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I. The MMP-9-1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. PLoS ONE. 2014;9(9):e106816.PubMedCrossRef
30.
go back to reference Lazăr L, Loghin A, Bud E-S, Cerghizan D, Horváth E, Nagy EE. Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease. Rom J Morphol Embryol. 2015;56(4):1441–6.PubMed Lazăr L, Loghin A, Bud E-S, Cerghizan D, Horváth E, Nagy EE. Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease. Rom J Morphol Embryol. 2015;56(4):1441–6.PubMed
31.
go back to reference Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. The Journal of clinical investigation. 1996;98(11):2572–9. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. The Journal of clinical investigation. 1996;98(11):2572–9.
32.
go back to reference Nosrati R, Kheirouri S, Ghodsi R, Ojaghi H. The effects of zinc treatment on matrix metalloproteinases: A systematic review. J Trace Elem Med Biol. 2019;56:107–15.PubMedCrossRef Nosrati R, Kheirouri S, Ghodsi R, Ojaghi H. The effects of zinc treatment on matrix metalloproteinases: A systematic review. J Trace Elem Med Biol. 2019;56:107–15.PubMedCrossRef
33.
go back to reference Mroczko B, Kozłowski M, Groblewska M, Lukaszewicz M, Nikliński J, Laudański J, et al. Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer. Folia Histochem Cytobiol. 2008;46(4):471–8.PubMed Mroczko B, Kozłowski M, Groblewska M, Lukaszewicz M, Nikliński J, Laudański J, et al. Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer. Folia Histochem Cytobiol. 2008;46(4):471–8.PubMed
34.
go back to reference Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium. 2007;14(4–5):193–8.PubMedCrossRef Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium. 2007;14(4–5):193–8.PubMedCrossRef
35.
go back to reference Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem. 1997;64(1):33–42.PubMedCrossRef Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem. 1997;64(1):33–42.PubMedCrossRef
36.
go back to reference Hu Q, Peng J, Liu W, He X, Cui L, Chen X, et al. Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int J Clin Exp Pathol. 2014;7(8):5057.PubMedPubMedCentral Hu Q, Peng J, Liu W, He X, Cui L, Chen X, et al. Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int J Clin Exp Pathol. 2014;7(8):5057.PubMedPubMedCentral
37.
go back to reference Khan S, Ahmad K, Alshammari E, Adnan M, Baig MH, Lohani M, et al. Implication of caspase-3 as a common therapeutic target for multineurodegenerative disorders and its inhibition using nonpeptidyl natural compounds. BioMed research international. 2015;2015. Khan S, Ahmad K, Alshammari E, Adnan M, Baig MH, Lohani M, et al. Implication of caspase-3 as a common therapeutic target for multineurodegenerative disorders and its inhibition using nonpeptidyl natural compounds. BioMed research international. 2015;2015.
38.
go back to reference Pradeep AR, Suke DK, Prasad MR, Singh SP, Martande SS, Nagpal K, et al. Expression of key executioner of apoptosis caspase-3 in periodontal health and disease. J Investig Clin Dent. 2016;7(2):174–9.PubMedCrossRef Pradeep AR, Suke DK, Prasad MR, Singh SP, Martande SS, Nagpal K, et al. Expression of key executioner of apoptosis caspase-3 in periodontal health and disease. J Investig Clin Dent. 2016;7(2):174–9.PubMedCrossRef
39.
go back to reference Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Experimental diabetes research. 2007;2007. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Experimental diabetes research. 2007;2007.
40.
go back to reference Kowluru RA, Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radical Res. 2002;36(9):993–9.CrossRef Kowluru RA, Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radical Res. 2002;36(9):993–9.CrossRef
41.
go back to reference Nakamura N, Hasegawa G, Obayashi H, Yamazaki M, Ogata M, Nakano K, et al. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2003;61(2):93–101.PubMedCrossRef Nakamura N, Hasegawa G, Obayashi H, Yamazaki M, Ogata M, Nakano K, et al. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2003;61(2):93–101.PubMedCrossRef
42.
go back to reference Ghanem AA, Elewa A, Arafa LF. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21(1):48–54.PubMedCrossRef Ghanem AA, Elewa A, Arafa LF. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21(1):48–54.PubMedCrossRef
43.
go back to reference Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, et al. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol. 2007;20(4):444–52.PubMed Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, et al. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol. 2007;20(4):444–52.PubMed
44.
go back to reference Kostov K, Blazhev A, Atanasova M, Dimitrova A. Serum concentrations of endothelin-1 and matrix metalloproteinases-2,-9 in pre-hypertensive and hypertensive patients with type 2 diabetes. Int J Mol Sci. 2016;17(8):1182.PubMedCentralCrossRef Kostov K, Blazhev A, Atanasova M, Dimitrova A. Serum concentrations of endothelin-1 and matrix metalloproteinases-2,-9 in pre-hypertensive and hypertensive patients with type 2 diabetes. Int J Mol Sci. 2016;17(8):1182.PubMedCentralCrossRef
45.
go back to reference Adedara IA, Fasina OB, Ayeni MF, Ajayi OM, Farombi EO. Protocatechuic acid ameliorates neurobehavioral deficits via suppression of oxidative damage, inflammation, caspase-3 and acetylcholinesterase activities in diabetic rats. Food Chem Toxicol. 2019;125:170–81.PubMedCrossRef Adedara IA, Fasina OB, Ayeni MF, Ajayi OM, Farombi EO. Protocatechuic acid ameliorates neurobehavioral deficits via suppression of oxidative damage, inflammation, caspase-3 and acetylcholinesterase activities in diabetic rats. Food Chem Toxicol. 2019;125:170–81.PubMedCrossRef
46.
go back to reference Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013;50(4):489–95.PubMedCrossRef Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013;50(4):489–95.PubMedCrossRef
47.
go back to reference Li L, Renier G. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis. 2009;204(1):40–6.PubMedCrossRef Li L, Renier G. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis. 2009;204(1):40–6.PubMedCrossRef
48.
go back to reference Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, et al. Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis. 2008;197(1):311–7.PubMedCrossRef Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, et al. Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis. 2008;197(1):311–7.PubMedCrossRef
49.
go back to reference Goldstein BJ, Weissman PN, Wooddell MJ, Waterhouse BR, Cobitz AR. Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study. Curr Med Res Opin. 2006;22(9):1715–23.PubMedCrossRef Goldstein BJ, Weissman PN, Wooddell MJ, Waterhouse BR, Cobitz AR. Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study. Curr Med Res Opin. 2006;22(9):1715–23.PubMedCrossRef
50.
go back to reference Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, et al. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev. 2011;132(11–12):583–7.PubMedPubMedCentralCrossRef Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, et al. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev. 2011;132(11–12):583–7.PubMedPubMedCentralCrossRef
51.
go back to reference Saulnier PJ, Wheelock KM, Howell S, Weil EJ, Tanamas SK, Knowler WC, et al. Advanced glycation end products predict loss of renal function and correlate with lesions of diabetic kidney disease in American Indians with type 2 diabetes. Diabetes. 2016;65(12):3744–53.PubMedPubMedCentralCrossRef Saulnier PJ, Wheelock KM, Howell S, Weil EJ, Tanamas SK, Knowler WC, et al. Advanced glycation end products predict loss of renal function and correlate with lesions of diabetic kidney disease in American Indians with type 2 diabetes. Diabetes. 2016;65(12):3744–53.PubMedPubMedCentralCrossRef
52.
go back to reference Foroumandi E, Alizadeh M, Kheirouri S. Age-dependent changes in plasma amino acids contribute to alterations in glycoxidation products. Journal of Medical Biochemistry. 2018;37(4):426–33.PubMedPubMedCentralCrossRef Foroumandi E, Alizadeh M, Kheirouri S. Age-dependent changes in plasma amino acids contribute to alterations in glycoxidation products. Journal of Medical Biochemistry. 2018;37(4):426–33.PubMedPubMedCentralCrossRef
53.
go back to reference Slowick-Zylka D, Safranow K, Dziedziejko V, Dutkiewicz G, Ciechanowski K, Chlubek D. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients. J Nephrol. 2006;19(1):65–9.PubMed Slowick-Zylka D, Safranow K, Dziedziejko V, Dutkiewicz G, Ciechanowski K, Chlubek D. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients. J Nephrol. 2006;19(1):65–9.PubMed
54.
go back to reference Vos P, Mastbergen S, Huisman A, de Boer T, DeGroot J, Polak A, et al. In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage. Osteoarthritis Cartilage. 2012;20(3):233–40.PubMedCrossRef Vos P, Mastbergen S, Huisman A, de Boer T, DeGroot J, Polak A, et al. In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage. Osteoarthritis Cartilage. 2012;20(3):233–40.PubMedCrossRef
55.
go back to reference Vos P, Welsing P, deGroot J, Huisman A, Oostveen J, Reijman M, et al. Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up. Osteoarthritis Cartilage. 2013;21(6):823–30.PubMedCrossRef Vos P, Welsing P, deGroot J, Huisman A, Oostveen J, Reijman M, et al. Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up. Osteoarthritis Cartilage. 2013;21(6):823–30.PubMedCrossRef
57.
go back to reference Van Deemter M, Ponsioen T, Bank R, Snabel J, Van der Worp R, Hooymans J, et al. Pentosidine accumulates in the aging vitreous body: a gender effect. Exp Eye Res. 2009;88(6):1043–50.PubMedCrossRef Van Deemter M, Ponsioen T, Bank R, Snabel J, Van der Worp R, Hooymans J, et al. Pentosidine accumulates in the aging vitreous body: a gender effect. Exp Eye Res. 2009;88(6):1043–50.PubMedCrossRef
58.
go back to reference Foroumandi E, Alizadeh M, Kheirouri S, Asghari JM. Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects. PLoS ONE. 2019;14(3):e0213307.PubMedCrossRef Foroumandi E, Alizadeh M, Kheirouri S, Asghari JM. Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects. PLoS ONE. 2019;14(3):e0213307.PubMedCrossRef
59.
go back to reference Semba RD, Kai S, Schwartz AV, Varadhan R, Harris TB, Satterfield S, et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens. 2015;33(4):797.PubMedPubMedCentralCrossRef Semba RD, Kai S, Schwartz AV, Varadhan R, Harris TB, Satterfield S, et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens. 2015;33(4):797.PubMedPubMedCentralCrossRef
60.
go back to reference Gaens KH, Ferreira I, Van de Waarenburg MP, van Greevenbroek MM, Van Der Kallen CJ, Dekker JM, et al. Protein-bound plasma Nε-(carboxymethyl) lysine is inversely associated with central obesity and inflammation and significantly explain a part of the central obesity–related increase in inflammation: The Hoorn and CODAM studies. Arterioscler Thromb Vasc Biol. 2015;35(12):2707–13.PubMedCrossRef Gaens KH, Ferreira I, Van de Waarenburg MP, van Greevenbroek MM, Van Der Kallen CJ, Dekker JM, et al. Protein-bound plasma Nε-(carboxymethyl) lysine is inversely associated with central obesity and inflammation and significantly explain a part of the central obesity–related increase in inflammation: The Hoorn and CODAM studies. Arterioscler Thromb Vasc Biol. 2015;35(12):2707–13.PubMedCrossRef
61.
go back to reference Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis. 2009;19(2):129–34.PubMedCrossRef Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis. 2009;19(2):129–34.PubMedCrossRef
62.
go back to reference Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr. 2011;141(9):1726–30.PubMedPubMedCentralCrossRef Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr. 2011;141(9):1726–30.PubMedPubMedCentralCrossRef
63.
go back to reference Makino N, Oyama JI, Maeda T, Koyanagi M, Higuchi Y, Tsuchida K. Calorie restriction increases telomerase activity, enhances autophagy, and improves diastolic dysfunction in diabetic rat hearts. Molecular and cellular biochemistry. 2015;403(1–2):1–11. Makino N, Oyama JI, Maeda T, Koyanagi M, Higuchi Y, Tsuchida K. Calorie restriction increases telomerase activity, enhances autophagy, and improves diastolic dysfunction in diabetic rat hearts. Molecular and cellular biochemistry. 2015;403(1–2):1–11.
64.
go back to reference Dan-Dan R, Jing L, CHANG B, Chun-Shen L, Ju-Hong Y. Early intervention with Didang decoction delays macrovascular lesions in diabetic rats through regulating AMP-activated protein kinase signaling pathway. Chinese journal of natural medicines. 2017;15(11):847–54. Dan-Dan R, Jing L, CHANG B, Chun-Shen L, Ju-Hong Y. Early intervention with Didang decoction delays macrovascular lesions in diabetic rats through regulating AMP-activated protein kinase signaling pathway. Chinese journal of natural medicines. 2017;15(11):847–54.
65.
go back to reference Rivera P, Pérez-Martín M, Pavón FJ, Serrano A, Crespillo A, Cifuentes M, et al. Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus. PLoS ONE. 2013;8(5):e64750.PubMedCrossRef Rivera P, Pérez-Martín M, Pavón FJ, Serrano A, Crespillo A, Cifuentes M, et al. Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus. PLoS ONE. 2013;8(5):e64750.PubMedCrossRef
66.
go back to reference Li SY, Liu Y, Sigmon V, McCort A, Ren J. High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis. Diabetes Obes Metab. 2005;7(4):448–54.PubMedCrossRef Li SY, Liu Y, Sigmon V, McCort A, Ren J. High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis. Diabetes Obes Metab. 2005;7(4):448–54.PubMedCrossRef
67.
go back to reference Ma L, Wang R, Dong W, Li Y, Xu B, Zhang J, et al. Long-term caloric restriction in mice may prevent age-related learning impairment via suppression of apoptosis. Behav Brain Res. 2016;315:45–50.PubMedCrossRef Ma L, Wang R, Dong W, Li Y, Xu B, Zhang J, et al. Long-term caloric restriction in mice may prevent age-related learning impairment via suppression of apoptosis. Behav Brain Res. 2016;315:45–50.PubMedCrossRef
68.
go back to reference Bengmark S. Advanced glycation and lipoxidation end products–amplifiers of inflammation: the role of food. J Parenter Enter Nutr. 2007;31(5):430–40.CrossRef Bengmark S. Advanced glycation and lipoxidation end products–amplifiers of inflammation: the role of food. J Parenter Enter Nutr. 2007;31(5):430–40.CrossRef
Metadata
Title
Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients
Authors
Elaheh Foroumandi
Sorayya Kheirouri
Rahmat Nosrati
Ramin Ghodsi
Publication date
01-06-2021
Publisher
Springer International Publishing
Keyword
Gliclazide
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00803-5

Other articles of this Issue 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Go to the issue